Kite Pharma, Inc. Marketable Securities (Current)
Kite Pharma, Inc. had Marketable Securities (Current) of $633.27 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2017-08-08
- 2017-06-30: Marketable Securities, Current $633.27M.
- 2017-03-31: Marketable Securities, Current $238.88M.
- 2016-12-31: Marketable Securities, Current $299.86M.
- 2016-09-30: Marketable Securities, Current $348.37M.
| Period end | Marketable Securities, Current |
|---|---|
| 2017-06-30 | $633.27M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $238.88M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $299.86M 10-Q · filed 2017-08-08 |
| 2016-09-30 | $348.37M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $360.97M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $377.82M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $221.88M 10-K · filed 2017-02-28 |
| 2015-09-30 | $195.60M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $129.65M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $144.61M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $157.74M 10-K · filed 2016-02-29 |
| 2014-09-30 | $116.37M 10-Q · filed 2014-11-14 |